10.1038/s41591-019-0654-5 - Integrative molecular and clinical mo...

This document has been corrected

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

10.1038/s41591-019-0654-5

Published Online: 2019-12-?

Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC

Authors: Adam Tracy•Angela Krackhardt•Annette Paschen•Antje Sucker•Aviv Regev•Bastian Schilling•Ben Izar•Benjamin Weide•Carmen Loquai•Christian U. Blank•Claire A. Margolis•Dagmar von Bubnoff•David Liu•Derek Liu•Diana Miao•Dirk Schadendorf•Eliezer M. Van Allen•Elisabeth Livingstone•Felix Dietlein•Felix Kiecker•Haitham Elmarakeby•Helen Gogas•Imke Satzger•Jake Conway•Jochen Utikal•Keith Flaherty•Levi Garraway•Lisa Zimmer•Livnat Jerby-Arnon•Meng Xiao He•Natalie Vokes•Ralf Gutzmer•Ricarda Rauschenberg•Sebastian Haferkamp•Simone M. Goldinger•Stephan Grabbe

This document has been corrected

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

10.1038/s41591-019-0654-5

Published Online: 2019-12-?

Journal: Nature Medicine

NOW

2020-06-19•Correction

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

10.1038/s41591-020-0975-4

* information provided by CrossRef

2020-06-19•Correction

10.1038/s41591-020-0975-4

* information provided by CrossRef

2019-12-?•Published

2020-06-19•Correction

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

10.1038/s41591-020-0975-4

* information provided by CrossRef

This document has been corrected

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

10.1038/s41591-019-0654-5

Published Online: 2019-12-?

Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC